NIH-funded research R01 grant

Understanding how immune cells adapt to infections

Official title: The IRF regulatory network in innate immune training of macrophages

Funded at University of California Los Angeles · NIH-11133932 · Data updated 2026-11-12

This study is looking at how certain immune cells called macrophages learn from past infections to better fight off future ones, which could help develop new ways to boost the immune system for people who need it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$643,718
NIH project number1R01AI185026-01A1
Project IDNIH-11133932 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that compromise their immune system or those at high risk for infections.

Less likely to help

Patients with stable immune function and no history of recurrent infections may not benefit from this research.

What this research studies

This research investigates how macrophages, key immune cells, adapt their responses to infections based on their previous encounters with pathogens. By examining the changes in the macrophage's genetic material, the study aims to uncover the mechanisms behind 'innate immune training,' which enhances the cells' ability to fight off future infections. The researchers will focus on specific proteins that regulate these changes and how they work together to influence immune responses. This could lead to new strategies for improving immune function in patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for infections by enhancing the immune response in patients.

How similar studies have gone: Previous research has shown promising results in understanding immune cell training, indicating that this approach has potential for significant advancements.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hoffmann, Alexander — University of California Los Angeles
  • Study coordinator: Hoffmann, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.